Buckingham Strategic Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $943K | Buy |
2,011
+229
| +13% | +$107K | 0.01% | 339 |
|
2024
Q1 | $745K | Buy |
1,782
+21
| +1% | +$8.78K | 0.01% | 387 |
|
2023
Q4 | $717K | Buy |
1,761
+251
| +17% | +$102K | 0.01% | 375 |
|
2023
Q3 | $525K | Buy |
1,510
+74
| +5% | +$25.7K | 0.01% | 410 |
|
2023
Q2 | $505K | Buy |
1,436
+159
| +12% | +$56K | 0.01% | 421 |
|
2023
Q1 | $369K | Hold |
1,277
| – | – | 0.01% | 447 |
|
2022
Q4 | $369K | Sell |
1,277
-29
| -2% | -$8.38K | 0.01% | 449 |
|
2022
Q3 | $378K | Buy |
1,306
+44
| +3% | +$12.7K | 0.01% | 420 |
|
2022
Q2 | $356K | Sell |
1,262
-15
| -1% | -$4.23K | 0.01% | 436 |
|
2022
Q1 | $333K | Buy |
1,277
+52
| +4% | +$13.6K | 0.01% | 446 |
|
2021
Q4 | $269K | Sell |
1,225
-8
| -0.6% | -$1.76K | 0.01% | 501 |
|
2021
Q3 | $224K | Buy |
1,233
+45
| +4% | +$8.18K | ﹤0.01% | 536 |
|
2021
Q2 | $240K | Sell |
1,188
-29
| -2% | -$5.86K | 0.01% | 511 |
|
2021
Q1 | $262K | Sell |
1,217
-171
| -12% | -$36.8K | 0.01% | 464 |
|
2020
Q4 | $328K | Buy |
1,388
+47
| +4% | +$11.1K | 0.02% | 402 |
|
2020
Q3 | $365K | Buy |
1,341
+470
| +54% | +$128K | 0.03% | 323 |
|
2020
Q2 | $253K | Sell |
871
-576
| -40% | -$167K | 0.02% | 345 |
|
2020
Q1 | $344K | Sell |
1,447
-346
| -19% | -$82.3K | 0.03% | 311 |
|
2019
Q4 | $393K | Sell |
1,793
-860
| -32% | -$189K | 0.04% | 293 |
|
2019
Q3 | $449K | Sell |
2,653
-807
| -23% | -$137K | 0.05% | 253 |
|
2019
Q2 | $634K | Sell |
3,460
-50
| -1% | -$9.16K | 0.07% | 207 |
|
2019
Q1 | $646K | Buy |
3,510
+1,321
| +60% | +$243K | 0.08% | 185 |
|
2018
Q4 | $363K | Sell |
2,189
-68
| -3% | -$11.3K | 0.06% | 240 |
|
2018
Q3 | $435K | Sell |
2,257
-215
| -9% | -$41.4K | 0.07% | 211 |
|
2018
Q2 | $420K | Buy |
2,472
+524
| +27% | +$89K | 0.07% | 205 |
|
2018
Q1 | $317K | Sell |
1,948
-200
| -9% | -$32.5K | 0.06% | 233 |
|
2017
Q4 | $322K | Sell |
2,148
-122
| -5% | -$18.3K | 0.07% | 231 |
|
2017
Q3 | $345K | Buy |
2,270
+5
| +0.2% | +$760 | 0.08% | 205 |
|
2017
Q2 | $292K | Buy |
2,265
+79
| +4% | +$10.2K | 0.07% | 221 |
|
2017
Q1 | $239K | Buy |
+2,186
| New | +$239K | 0.07% | 214 |
|
2016
Q1 | – | Sell |
-2,162
| Closed | -$272K | – | 252 |
|
2015
Q4 | $272K | Sell |
2,162
-144
| -6% | -$18.1K | 0.09% | 151 |
|
2015
Q3 | $240K | Sell |
2,306
-15
| -0.6% | -$1.56K | 0.08% | 160 |
|
2015
Q2 | $287K | Sell |
2,321
-48
| -2% | -$5.94K | 0.09% | 160 |
|
2015
Q1 | $279K | Buy |
2,369
+58
| +3% | +$6.83K | 0.11% | 152 |
|
2014
Q4 | $275K | Sell |
2,311
-83
| -3% | -$9.88K | 0.11% | 147 |
|
2014
Q3 | $269K | Sell |
2,394
-13
| -0.5% | -$1.46K | 0.11% | 130 |
|
2014
Q2 | $228K | Buy |
+2,407
| New | +$228K | 0.1% | 150 |
|
2013
Q4 | – | Sell |
-2,825
| Closed | -$214K | – | 166 |
|
2013
Q3 | $214K | Sell |
2,825
-225
| -7% | -$17K | 0.11% | 119 |
|
2013
Q2 | $244K | Buy |
+3,050
| New | +$244K | 0.14% | 105 |
|